December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Large Submacular Hemorrhage Following Photodynamic Thrapy
Author Affiliations & Notes
  • NA Chaudhry
    New England Retina Assoc Hamden CT
  • DE Tom
    New England Retina Assoc Hamden CT
  • PE Liggett
    New England Retina Assoc Hamden CT
  • Footnotes
    Commercial Relationships   N.A. Chaudhry, None; D.E. Tom, None; P.E. Liggett, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 599. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      NA Chaudhry, DE Tom, PE Liggett; Large Submacular Hemorrhage Following Photodynamic Thrapy . Invest. Ophthalmol. Vis. Sci. 2002;43(13):599.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To report a case series of patients who developed large submacular hemorrhage following photodynamic therapy (PDT). Methods:We retrospectively reviewed charts of all patients who developed large submacular hemorrhage following PDT for various macular disorders between June 2000 and November 2001. Large submacular hemorrhage was defined as being 2 mm or more in thickness and extending up to or beyond the temporal arcades. Results:Three patients met the criteria for large submacular hemorrhage. All three patients were treated for exudative age-related macular degeneration (ARMD) and were on warfarin for chronic anticoagulation. The pre-PDT INR ranged from 1.2 to 1.6. All three hemorrhages were not noted immediately after PDT but documented within 1 to 2 weeks following the procedure. Conclusion:Large submacular hemorrhage is a rare complication of PDT. Patients with ARMD on warfarin therapy appear to be mainly at risk.

Keywords: 460 macula/fovea 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×